U.S. Agency Rejects Teva Bid to Extend Patent on Copaxone

Four of Teva's patents on flagship multiple sclerosis drug set to expire next month.

comments Print

The U.S. Patent Office on Friday rejected a request by Teva Pharmaceutical Industries to extend one of several patents on its...